All lobbying filings

W Strategies, LLC

W Strategies, LLC filed a Q2 report for Dyne Therapeutics, Inc. on July 20, 2026, reporting $40,000 in lobbying income.

Lobbying for Dyne Therapeutics, Inc. · A biotechnology company developing nucleic acid therapies for rare diseases.

As filed: W STRATEGIES, LLC for DYNE THERAPEUTICS, INC.

All filings by W Strategies, LLC · Everything Dyne Therapeutics, Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Lobbyists on this filing 1

DARREN WILLCOX

Previously held: Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 1

HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Education about access to rare disease therapies.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.